Post Hoc Subgroup Analyses of the Efficacy and Safety of Zavegepant for the Acute Treatment of Migraine According to Baseline Triptan Experience.

Pavlovic JM, Lipton RB, Joshi S, Fountaine R, Mosher LO

Open source

DOI
10.2147/jpr.s582708
Published
2026
Container
Journal of pain research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/jpr.s582708,
  title = {Post Hoc Subgroup Analyses of the Efficacy and Safety of Zavegepant for the Acute Treatment of Migraine According to Baseline Triptan Experience.},
  author = {Pavlovic JM and Lipton RB and Joshi S and Fountaine R and Mosher LO},
  year = {2026},
  journal = {Journal of pain research},
  doi = {10.2147/jpr.s582708},
  url = {https://doi.org/10.2147/jpr.s582708}
}

RIS

TY  - JOUR
TI  - Post Hoc Subgroup Analyses of the Efficacy and Safety of Zavegepant for the Acute Treatment of Migraine According to Baseline Triptan Experience.
AU  - Pavlovic JM
AU  - Lipton RB
AU  - Joshi S
AU  - Fountaine R
AU  - Mosher LO
PY  - 2026
JO  - Journal of pain research
DO  - 10.2147/jpr.s582708
UR  - https://doi.org/10.2147/jpr.s582708
ER  - 

APA

JM, P., RB, L., S, J., R, F., & LO, M. (2026). Post Hoc Subgroup Analyses of the Efficacy and Safety of Zavegepant for the Acute Treatment of Migraine According to Baseline Triptan Experience.. Journal of pain research. https://doi.org/10.2147/jpr.s582708

Source records